7th Eurasian Hematology Oncology Summit

 

7th Eurasian Hematology Oncology Summit
Avatar

2020 Updates on MDS: Role of Prognostic Models, Cytogenetics, IPSS, Genomics, Comorbidites, Response to HMA

By 7th Eurasian Hematology Oncology Summit FEATURING Guillermo Garcia-Manero
By 7th Eurasian Hematology Oncology Summit FEATURING Guillermo Garcia-Manero
0 views
December 11, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
MDS and MPN
15:05
7th Eurasian Hematology Oncology Summit

2020 Updates on MDS: Is Deferasirox Beneficial for EFS? Can We Achie…

Feat. G. Garcia-Manero
18:36
7th Eurasian Hematology Oncology Summit

2020 Update on High-Risk MDS: Does Aza Improve OS/ORR? How to Minimi…

Feat. M. Mittelman
11:32
7th Eurasian Hematology Oncology Summit

2020 Updates on MDS: Role of Prognostic Models, Cytogenetics, IPSS, …

Feat. G. Garcia-Manero
26:20
7th Eurasian Hematology Oncology Summit

2020 Update on MPNs: What Is the Risk Adapted Management in PV? Is R…

Feat. T. Mughal